Global DNA Sequencer Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 DNA Sequencer Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global DNA Sequencer Market Size Growth Rate by Product
- 1.4.2 Emulsion PCR
- 1.4.3 Bridge Amplification
- 1.4.4 Single-molecule
- 1.4.5 PCR
- 1.5 Market by End User
- 1.5.1 Global DNA Sequencer Market Size Growth Rate by End User
- 1.5.2 Molecular Biology
- 1.5.3 Evolutionary Biology
- 1.5.4 Metagenomics
- 1.5.5 Medicine
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global DNA Sequencer Market Size
- 2.1.1 Global DNA Sequencer Revenue 2014-2025
- 2.1.2 Global DNA Sequencer Sales 2014-2025
- 2.2 DNA Sequencer Growth Rate by Regions
- 2.2.1 Global DNA Sequencer Sales by Regions
- 2.2.2 Global DNA Sequencer Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 DNA Sequencer Sales by Manufacturers
- 3.1.1 DNA Sequencer Sales by Manufacturers
- 3.1.2 DNA Sequencer Sales Market Share by Manufacturers
- 3.1.3 Global DNA Sequencer Market Concentration Ratio (CR5 and HHI)
- 3.2 DNA Sequencer Revenue by Manufacturers
- 3.2.1 DNA Sequencer Revenue by Manufacturers (2014-2019)
- 3.2.2 DNA Sequencer Revenue Share by Manufacturers (2014-2019)
- 3.3 DNA Sequencer Price by Manufacturers
- 3.4 DNA Sequencer Manufacturing Base Distribution, Product Types
- 3.4.1 DNA Sequencer Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers DNA Sequencer Product Type
- 3.4.3 Date of International Manufacturers Enter into DNA Sequencer Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global DNA Sequencer Sales by Product
- 4.2 Global DNA Sequencer Revenue by Product
- 4.3 DNA Sequencer Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global DNA Sequencer Breakdown Data by End User
6 North America
- 6.1 North America DNA Sequencer by Countries
- 6.1.1 North America DNA Sequencer Sales by Countries
- 6.1.2 North America DNA Sequencer Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America DNA Sequencer by Product
- 6.3 North America DNA Sequencer by End User
7 Europe
- 7.1 Europe DNA Sequencer by Countries
- 7.1.1 Europe DNA Sequencer Sales by Countries
- 7.1.2 Europe DNA Sequencer Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe DNA Sequencer by Product
- 7.3 Europe DNA Sequencer by End User
8 Asia Pacific
- 8.1 Asia Pacific DNA Sequencer by Countries
- 8.1.1 Asia Pacific DNA Sequencer Sales by Countries
- 8.1.2 Asia Pacific DNA Sequencer Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific DNA Sequencer by Product
- 8.3 Asia Pacific DNA Sequencer by End User
9 Central & South America
- 9.1 Central & South America DNA Sequencer by Countries
- 9.1.1 Central & South America DNA Sequencer Sales by Countries
- 9.1.2 Central & South America DNA Sequencer Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America DNA Sequencer by Product
- 9.3 Central & South America DNA Sequencer by End User
10 Middle East and Africa
- 10.1 Middle East and Africa DNA Sequencer by Countries
- 10.1.1 Middle East and Africa DNA Sequencer Sales by Countries
- 10.1.2 Middle East and Africa DNA Sequencer Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa DNA Sequencer by Product
- 10.3 Middle East and Africa DNA Sequencer by End User
11 Company Profiles
- 11.1 Roche
- 11.1.1 Roche Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Roche DNA Sequencer Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Roche DNA Sequencer Products Offered
- 11.1.5 Roche Recent Development
- 11.2 Illumina
- 11.2.1 Illumina Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Illumina DNA Sequencer Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Illumina DNA Sequencer Products Offered
- 11.2.5 Illumina Recent Development
- 11.3 Life Technologies
- 11.3.1 Life Technologies Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Life Technologies DNA Sequencer Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Life Technologies DNA Sequencer Products Offered
- 11.3.5 Life Technologies Recent Development
- 11.4 Beckman Coulter
- 11.4.1 Beckman Coulter Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Beckman Coulter DNA Sequencer Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Beckman Coulter DNA Sequencer Products Offered
- 11.4.5 Beckman Coulter Recent Development
- 11.5 Pacific Biosciences
- 11.5.1 Pacific Biosciences Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Pacific Biosciences DNA Sequencer Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Pacific Biosciences DNA Sequencer Products Offered
- 11.5.5 Pacific Biosciences Recent Development
- 11.6 Oxford Nanopore
- 11.6.1 Oxford Nanopore Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Oxford Nanopore DNA Sequencer Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Oxford Nanopore DNA Sequencer Products Offered
- 11.6.5 Oxford Nanopore Recent Development
- 11.7 Abbott Laboratories
- 11.7.1 Abbott Laboratories Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Abbott Laboratories DNA Sequencer Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Abbott Laboratories DNA Sequencer Products Offered
- 11.7.5 Abbott Laboratories Recent Development
- 11.8 GE Healthcare Life Sciences
- 11.8.1 GE Healthcare Life Sciences Company Details
- 11.8.2 Company Business Overview
- 11.8.3 GE Healthcare Life Sciences DNA Sequencer Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 GE Healthcare Life Sciences DNA Sequencer Products Offered
- 11.8.5 GE Healthcare Life Sciences Recent Development
- 11.9 Johnson & Johnson
- 11.9.1 Johnson & Johnson Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Johnson & Johnson DNA Sequencer Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Johnson & Johnson DNA Sequencer Products Offered
- 11.9.5 Johnson & Johnson Recent Development
12 Future Forecast
- 12.1 DNA Sequencer Market Forecast by Regions
- 12.1.1 Global DNA Sequencer Sales Forecast by Regions 2019-2025
- 12.1.2 Global DNA Sequencer Revenue Forecast by Regions 2019-2025
- 12.2 DNA Sequencer Market Forecast by Product
- 12.2.1 Global DNA Sequencer Sales Forecast by Product 2019-2025
- 12.2.2 Global DNA Sequencer Revenue Forecast by Product 2019-2025
- 12.3 DNA Sequencer Market Forecast by End User
- 12.4 North America DNA Sequencer Forecast
- 12.5 Europe DNA Sequencer Forecast
- 12.6 Asia Pacific DNA Sequencer Forecast
- 12.7 Central & South America DNA Sequencer Forecast
- 12.8 Middle East and Africa DNA Sequencer Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 DNA Sequencer Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
The global DNA Sequencer market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the DNA Sequencer market based on company, product type, end user and key regions.
This report studies the global market size of DNA Sequencer in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of DNA Sequencer in these regions.
This research report categorizes the global DNA Sequencer market by top players/brands, region, type and end user. This report also studies the global DNA Sequencer market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche
Illumina
Life Technologies
Beckman Coulter
Pacific Biosciences
Oxford Nanopore
Abbott Laboratories
GE Healthcare Life Sciences
Johnson & Johnson
Market size by Product
Emulsion PCR
Bridge Amplification
Single-molecule
PCR
Market size by End User
Molecular Biology
Evolutionary Biology
Metagenomics
Medicine
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global DNA Sequencer market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of DNA Sequencer market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global DNA Sequencer companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of DNA Sequencer submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of DNA Sequencer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of DNA Sequencer market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.